Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Psychology|February 2, 2017
The Buffering Effect of Workplace Resources on the Relationship between the Areas of Worklife and BurnoutPaul Jimenez, Anita Dunkl
Evolution; International Journal of Organic Evolution|May 6, 2021
Density-dependent private benefit leads to bacterial mutualismPaul Jimenez, István Scheuring
Frontiers in Psychology|May 7, 2025
Oceanic feelings and their relationship to spirituality and personality organizationSarah Straßnig, Tobias Herzl, Afrodita Latifi, et al.
Optics Express|May 8, 2023
Minimum complexity integrated photonic architecture for delay-based reservoir computingMohab Abdalla, Clément Zrounba, Raphael Cardoso, et al.
Targeted Oncology|August 1, 2014
The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancerDonald L Smith, Jaime Acquaviva, Manuel Sequeira, et al.
Molecular Cancer Therapeutics|January 9, 2014
Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespibJaime Acquaviva, Donald L Smith, John-Paul Jimenez, et al.
Molecular Cancer Research : MCR|May 3, 2014
FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolismJaime Acquaviva, Suqin He, Chaohua Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2013
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancerDavid A Proia, Chaohua Zhang, Manuel Sequeira, et al.
Molecular Cancer Therapeutics|August 15, 2015
HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to TumorsDavid A Proia, Donald L Smith, Junyi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 19, 2012
Ganetespib (STA-9090), a nongeldanamycin HSP90 inhibitor, has potent antitumor activity in in vitro and in vivo models of non-small cell lung cancerTakeshi Shimamura, Samanthi A Perera, Kevin P Foley, et al.
Pageof 2